| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.73 | 0.005 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |